[Intrathecal baclofen pump in spastic patients]
Klappenbach R, Bardach A, Alcaraz A, Pichon-Riviere A, Augustovski F, García Martí S, Ciapponi A.
Record ID 32018001590
Spanish
Original Title:
Baclofeno intratecal por bomba en pacientes con espasticidad
Authors' recommendations:
Low-quality evidence suggests that intrathecal baclofen by continuous infusion pump when compared with the best supportive care for patients with severe chronic spasticity secondary to different conditions and refractory to oral medication might considerably improve quality of life and spasticity at middle term. No good-quality evidence comparing this technology with another active therapy has been found.
There is consensus among the clinical practice guidelines and coverage policies consulted on using this technology for spasticity refractory to oral therapy. Some of them limit its use in patients who have failed with other treatments (botulinum toxin, cannabinoids and/or certain types of spasticity (generalized or regional).
In Argentina, the cost-effectiveness of this technology is unknown.
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Movement Disorders
- Muscle Relaxants, Central
- Baclofen
- Muscle Spasticity
- Infusion Pumps
- Infusions, Spinal
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.